Axial Length Change in Eyes Treated by Silicone Sponge Scleral Buckling
NCT ID: NCT01647373
Last Updated: 2013-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2013-07-31
2014-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
1ry Versus 2ry ILM Peeling in RD
NCT07346560
Treating Rhegmatogenous Retinal Detachment by Foldable Capsular Buckle
NCT04571788
Internal Limiting Membrane Flap in the Management of Retinal Detachment Due to Paracentral Retinal Breaks
NCT03707015
ILM Peeling in PDR Patients Undergoing PPV for VH
NCT03660371
Foldable Capsular Scleral Buckling Versus Vitrectomy in Medium-complex Rhegmatogenous Retinal Detachment Treatment
NCT06610786
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with silicone sponge scleral buckling
* currently attached
* with IOL Master pre-surgery Axial Length measurement
Exclusion Criteria
* patients with vitreos silicone oil tamponade
* patients with radial or other non-circumference buckles
* patients with unclear media not amenable to IOL Master exam
18 Years
90 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Meir Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alex Rubowitz, MD
Role: PRINCIPAL_INVESTIGATOR
Retina Service, Meir Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Meir hospital, dept. Of ophthalmology
Kfar Saba, , Israel
Retina Service, Meir Hospital
Kfar Saba, , Israel
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0125-12
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.